Eliem Therapeutics shares owned by Bridgeway Capital Management
Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Bridgeway Capital Management
from 13F filings
Historical chart of Bridgeway Capital Management investment in Eliem Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Eliem Therapeutics held by Bridgeway Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eliem Therapeutics by Bridgeway Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $220k | 109k | 2.01 |
| 2025-06-30 | $167k | 134k | 1.24 |
| 2025-03-31 | $164k | 134k | 1.22 |
| 2024-06-30 | $393k | 55k | 7.11 |
| 2024-03-31 | $151k | 55k | 2.74 |
| 2023-09-30 | $146k | 55k | 2.64 |
| 2023-06-30 | $155k | 55k | 2.80 |
| 2023-03-31 | $160k | 55k | 2.90 |
| 2022-12-31 | $198k | 55k | 3.58 |
| 2022-09-30 | $178k | 55k | 3.22 |
| 2022-06-30 | $62k | 20k | 3.04 |
| 2022-03-31 | $154k | 18k | 8.37 |
More positions owned by Bridgeway Capital Management
View all positions for Bridgeway Capital Management